Front Row Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-71
Closed -$26.6K 661
2024
Q2
$26.6K Sell
71
-9
-11% -$3.04K 0.01% 357
2024
Q1
$27.8K Buy
+80
New +$30.3K 0.01% 337
2023
Q4
Sell
-71
Closed -$34.6K 625
2023
Q3
$34.6K Sell
71
-2
-3% -$940 0.02% 279
2023
Q2
$33K Sell
73
-3
-4% -$1.51K 0.01% 288
2023
Q1
$37K Hold
76
0.02% 274
2022
Q4
$39K Hold
76
0.02% 265
2022
Q3
$37K Sell
76
-1
-1% -$486 0.02% 269
2022
Q2
$36K Hold
77
0.02% 278
2022
Q1
$34K Hold
77
0.01% 309
2021
Q4
$36K Sell
77
-3
-4% -$1.33K 0.01% 309
2021
Q3
$31K Hold
80
0.01% 327
2021
Q2
$33K Hold
80
0.01% 321
2021
Q1
$34K Sell
80
-4
-5% -$1.6K 0.02% 310
2020
Q4
$35K Hold
84
0.02% 297
2020
Q3
$34K Sell
84
-8
-9% -$3.22K 0.02% 292
2020
Q2
$36K Sell
92
-1
-1% -$374 0.02% 256
2020
Q1
$36K Sell
93
-7
-7% -$2.36K 0.02% 254
2019
Q4
$37K Buy
100
+3
+3% +$952 0.02% 234
2019
Q3
$25K Buy
97
+12
+14% +$3.36K 0.02% 279
2019
Q2
$23K Sell
85
-10
-11% -$2.54K 0.02% 298
2019
Q1
$25K Sell
95
-2
-2% -$576 0.02% 280
2018
Q4
$28K Hold
97
0.02% 250
2018
Q3
$31K Sell
97
-2
-2% -$650 0.02% 251
2018
Q2
$31K Buy
99
+9
+10% +$2.64K 0.02% 274
2018
Q1
$24K Sell
90
-3
-3% -$812 0.02% 307
2017
Q4
$23K Buy
+93
New +$23K 0.02% 323

Other funds holding HUM

Front Row Advisors's HUM Position: Q3 2024 in Review

Front Row Advisors sold out of Humana (HUM) in Q3 2024, closing a stake of 71 shares — an estimated $26.6K sold.

Front Row Advisors first reported a position in HUM in Q4 2017 and held it in 26 quarters. The position peaked at $39K in Q4 2022. 940 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

  • Front Row Advisors reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 71 Humana shares in Q3 2024, an estimated $26.6K.
  • Front Row Advisors first reported a position in Humana in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Humana position peaked at $39K in Q4 2022.
  • 940 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.